Readying For a Biotech Bounce With XBI
October 09, 2019 at 10:35 AM EDT
The SPDR S&P Biotech ETF (XBI) and rival biotechnology ETFs are coming off the third quarter and have recently been beset by outflows, but some market observers believe the group offers rebound potential. The biotech segment and broader healthcare sector have also underperformed the broader...